What is the share price of Vivek PharmaChem (India) Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Vivek PharmaChem (India) Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Vivek PharmaChem (India)?

The latest standalone P/E ratio of Vivek PharmaChem (India) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Vivek PharmaChem (India) Ltd?

The latest standalone P/B ratio of Vivek PharmaChem (India) Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Vivek PharmaChem (India) Ltd?

The 52-week high of Vivek PharmaChem (India) Ltd is Rs. and the 52-week low is Rs. .

Vivek PharmaChem (India) Ltd Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Vivek PharmaChem (India) Ltd
Brand: Vivek PharmaChem (India)

Vivek PharmaChem (India) Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Vivek PharmaChem Share Price

Vivek PharmaChem (India) Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Vivek PharmaChem Share Price

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹4.8

TTM Sales

₹149 Cr.

Book Value per Share

₹34.8

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

14.91%

Return on Capital Employed (ROCE)

14.16%

Return on Assets (ROA)

5.04%

Operating Profit Margin

12.3%

Net Profit Margin

4.62%

Gross Profit Margin

8.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-29.51%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-25.65%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

-17.31%

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹35 Cr.

Equity

₹14.3 Cr.

Face Value

₹10

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'19	Mar'20	Mar'21	TTM
ROCE % ⓘ	14.3%	14.6%	13.2%	9.5%	8.4%	13.3%	12.9%	16.1%	19.5%	14.2%	-
Value Creation Index ⓘ	0.0	0.0	-0.1	-0.3	-0.4	-0.1	-0.1	0.2	0.4	0.0	-
Growth Parameters ⓘ
Sales ⓘ	49	49.5	74.4	88.6	76.6	99.1	99.5	134	211	149	149
Sales YoY Gr.	-	0.9%	50.3%	19.2%	-13.6%	29.4%	0.4%	35%	57.3%	-29.5%	-
Adj EPS ⓘ	0.9	0.3	0.6	0.5	0.7	-1.1	1	5.2	5.8	4.8	4.8
YoY Gr.	-	-69.7%	137%	-21.9%	34%	-265.7%	NA	409.8%	12.3%	-17.5%	-
BVPS (₹) ⓘ	9.6	9.6	11	11.5	12.3	11.1	12.1	24.1	30	34.8	34.8
Adj Net Profit ⓘ	1.3	0.4	0.9	0.7	1	-1.6	1.5	7.4	8.3	6.9	7
Cash Flow from Ops. ⓘ	8.1	-2.6	12.9	3	0.1	10.8	17	17.9	12.9	9.7	-
Debt/CF from Ops. ⓘ	1.7	-7.6	2.8	14	369.8	5	3.3	3	3.3	3.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	13.1%	14.2%	14.4%	-29.5%
Adj EPS ⓘ	20.7%	48.4%	67.8%	-17.5%
BVPSⓘ	15.4%	23.2%	42.1%	16.1%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'19	Mar'20	Mar'21	TTM
Return on Equity % ⓘ	9.7	2.8	6.2	4.4	5.6	-9.5	8.8	28.7	21.6	14.9	13.9
Op. Profit Mgn % ⓘ	13.9	15.3	12.1	13.8	13.4	14.1	15.9	15.3	11.7	12.3	NAN
Net Profit Mgn % ⓘ	2.6	0.8	1.2	0.8	1.3	-1.6	1.5	5.5	3.9	4.6	4.6
Debt to Equity ⓘ	1	1.4	2.3	2.5	2.2	3.4	3.3	1.6	1	0.7	-
Working Cap Days ⓘ	148	169	141	125	137	124	148	137	134	188	0
Cash Conv. Cycle ⓘ	46	51	52	60	80	58	54	38	35	44	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'19	Mar'20	Mar'21
Sales	49.03	49.46	74.36	88.64	76.61	99.10	99.47	134.23	211.18	148.87
Operating Expenses ⓘ +	42.34	41.91	65.37	76.45	66.32	85.11	83.67	113.73	186.54	130.55
Manufacturing Costs	8.67	8.53	1.58	0	0	11.21	13.48	21.84	29.16	21.19
Material Costs	26.11	24.65	52.17	61.60	56.76	60.04	58.28	72.26	123.06	85.62
Employee Cost	1.76	1.96	2.89	3.45	3.23	3.93	3.87	6.71	8	7.57
Other Costs ⓘ	5.80	6.77	8.72	11.40	6.33	9.93	8.04	12.92	26.33	16.18
Operating Profit ⓘ	6.69	7.55	8.99	12.19	10.30	13.99	15.80	20.50	24.64	18.32
Operating Profit Margin (%)	13.6%	15.3%	12.1%	13.8%	13.4%	14.1%	15.9%	15.3%	11.7%	12.3%
Other Income ⓘ +	0.02	0.28	0.06	0.09	0.39	0.05	0.24	0.49	0.12	0.65
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	1.75	2.06	3.22	3.69	3.23	4.79	5.93	6.15	7.17	4.86
Depreciation ⓘ	2.44	3.41	3.48	7.06	5.96	5.77	6.81	7.93	7.84	7.20
Profit Before Tax ⓘ	2.52	2.35	2.36	1.53	1.50	3.48	3.31	6.91	9.75	6.92
Tax ⓘ	1.33	1.98	1.44	0.79	0.46	5.06	1.85	-0.51	1.44	0.04
Profit After Tax	1.20	0.37	0.92	0.74	1.04	-1.58	1.45	7.42	8.32	6.88
PAT Margin (%)	2.4%	0.8%	1.2%	0.8%	1.4%	-1.6%	1.5%	5.5%	3.9%	4.6%
Adjusted EPS (₹)	0.8	0.3	0.6	0.5	0.7	-1.1	1.0	5.2	5.8	4.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Vivek PharmaChem - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'19	Mar'20	Mar'21
Equity and Liabilities
Shareholders Fund +	13.62	13.63	15.70	16.44	17.48	15.82	17.27	34.37	42.69	49.56
Share Capital ⓘ	9.87	9.87	14.25	14.25	14.25	14.25	14.25	14.25	14.25	14.25
Reserves ⓘ	3.75	3.76	1.44	2.19	3.23	1.57	3.02	20.12	28.44	35.31
Debt +	13.84	19.47	30.58	37.55	34.46	48.68	49.80	45.57	32.53	25.86
Long Term Debt	13.84	15.89	26.12	24.35	23.59	32.26	38.22	30.49	25.37	25.86
Short Term Debt	0	3.58	4.46	13.20	10.87	16.42	11.58	15.08	7.16	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	13.39	8.21	16.96	6.41	8.95	14.54	19.30	32	51.09	31.09
Others Liabilities ⓘ	7.16	6.16	20.40	20.65	12.71	17.41	20.16	22.04	22.89	17.21
Total Liabilities ⓘ	48	47.47	83.63	81.05	73.60	96.46	106.53	133.99	149.20	123.73
Fixed Assets
Net Fixed Assets ⓘ +	24.92	21.53	47.97	41.11	33.53	46.01	59.68	53.85	48.50	41.97
Gross Block	40.07	40.09	69.97	70.09	66.59	84.91	105.40	122.39	124.87	125.26
Accumulated Depreciation	15.15	18.56	22	28.98	33.06	38.90	45.72	68.54	76.38	83.29
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0.02
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	4.57	2.93	6.89	4.74	4.91	8.55	6.51	15.99	13.80	9.73
Trade Receivables	15.46	16.87	25.61	22.24	21.89	26.49	32.86	48.69	71.77	49.29
Cash Equivalents	0.85	1.03	0.66	10.16	8.75	9.71	0.89	1.66	2.09	6.62
Others Assets ⓘ	2.20	5.11	2.49	2.81	4.52	5.69	6.59	13.80	13.05	16.09
Total Assets ⓘ	48	47.47	83.63	81.05	73.60	96.46	106.53	133.99	149.20	123.73

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'19	Mar'20	Mar'21
Cash Flow From Operating Activity ⓘ +	8.09	-2.56	12.93	2.96	0.10	10.75	16.97	17.92	12.87	9.65
PBT ⓘ	2.52	2.35	2.36	1.53	1.50	3.48	3.31	6.91	9.75	6.92
Adjustment ⓘ	3.29	4.95	4.45	7.05	4.47	10.52	12.50	13.58	14.95	11.02
Changes in Working Capital ⓘ	3.61	-7.53	7.57	-5.15	-5.56	-2.55	1.85	-1.26	-10.28	-7.19
Tax Paid ⓘ	-1.33	-2.34	-1.44	-0.47	-0.31	-0.70	-0.68	-1.32	-1.55	-1.09
Cash Flow From Investing Activity ⓘ +	-8.36	-0.03	-29.81	-0.44	1.59	-19.23	-20.98	-9.82	-0.17	-1.16
Capex	-8.36	-0.03	-29.92	-0.19	3.11	-18.34	-20.49	-9.14	-2.48	-0.61
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0.11	-0.25	-1.52	-0.90	-0.50	-0.68	2.31	-0.55
Cash Flow From Financing Activity ⓘ +	-3.32	2.77	16.51	6.97	-3.10	9.44	-4.81	-7.96	-12.26	-3.96
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-3.37	2.37	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	-4.79	-5.93	-6.05	-7.14	-4.45
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.05	0.40	16.51	6.97	-3.10	14.23	1.11	-1.90	-5.12	0.49
Net Cash Flow ⓘ	-3.59	0.18	-0.37	9.49	-1.40	0.96	-8.83	0.14	0.44	4.53

Financial Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'19	Mar'20	Mar'21
Ratios
ROE (%)	9.19	2.75	6.24	4.62	6.14	-9.49	8.78	28.73	21.59	14.91
ROCE (%)	14.27	14.59	13.15	9.53	8.37	13.26	12.91	16.12	19.53	14.16
Asset Turnover Ratio	1.13	1.08	1.2	1.15	1.05	1.25	1.06	1.38	1.7	1.23
PAT to CFO Conversion(x)	6.74	-6.92	14.05	4	0.1	N/A	11.7	2.42	1.55	1.4
Working Capital Days
Receivable Days	107.30	113.90	98.70	92.60	99.10	83.10	101	89.90	91.20	131.10
Inventory Days	26.10	26.40	22.80	22.50	21.70	23.10	25.70	24.80	22.60	25.50
Payable Days	146.10	160	88	69.20	49.40	71.40	106	129.60	123.20	175.20

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vivek PharmaChem (India) Ltd FAQs

The current trading price of Vivek PharmaChem on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vivek PharmaChem stood at ₹0.00 Cr

The latest P/E ratio of Vivek PharmaChem as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Vivek PharmaChem as of 31-Dec-1969 is 0.00.

The 52-week high of Vivek PharmaChem is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vivek PharmaChem is ₹149 ( Cr.) .

Data is not available for this company.

No data found

About Vivek PharmaChem (India) Ltd

No data to display

Vivek PharmaChem (India) Ltd

Vivek PharmaChem (India) Ltd

10 Year X-Ray :